Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can…

Perennial Allergic Rhinitis (PAR)

Eli Lilly and CompanyNCT06339008